Tao Fu

Tao Fu General Information

Biography

Mr. Tao Fu is a Co-Founder and serves as Chief Executive Officer and Board member at Attovia. Mr. Fu serves as Board Member at Tr1x. He has been our Director since 2017 and has served as our company's Chief Operating Officer since September 2018. He serves as a Venture Partner at Frazier Healthcare Partners. Prior to joining our company, he was Executive Vice President, Chief Commercial and Business Officer of Portola Pharmaceuticals, Inc., a publicly traded biotechnology company specializing in cardiovascular disease, hematological disorders, and cancer from June 2015 to September 2018. Prior to joining Portola in June 2015, he was Vice President, of business development, and head of M&A and alliance management at BMS. He led all M&A, divestiture, strategic transaction, and venture investment opportunities as well as alliance management for BMS. Between 2003 and 2015, He worked at Johnson & Johnson in a number of roles, most recently as Vice President, of business development, where he was responsible for global M&A activities in the pharmaceutical sector. Prior to joining Johnson & Johnson, he held managerial positions with Scios Inc., a biotechnology company in California; McKinsey &Company, a global management consulting firm; and Becton Dickinson, a leading medical device company. He received a master of science in cell biology from the University of Rochester, and a master of business administration in finance and marketing from Vanderbilt University. He did his undergraduate studies in biology at Tsinghua University and is a Chartered Financial Analyst (CFA).